Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
Mansoura University Hospitals, Mansoura, DK, Egypt
King Fahd Hospital of the University, Dammam, Eastern, Saudi Arabia
Mount Sinai Hospital, Toronto, Ontario, Canada
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
West Coast Clinical Trials, Cypress, California, United States
Departement of Anesthesiology and Intensive Care of the University of Rome "La Sapienza" Viale del Policlinico 155, Rome, Italy
Washington University School of Medicine, Saint Louis, Missouri, United States
University of Utah, Salt Lake City, Utah, United States
Department of Anesthesiology and Intensive care of the University of Rome "La Sapienza", Rome, Italy
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.